Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$1.66
+2.2%
$1.75
$1.46
$37.50
$2.44M0.47664,367 shs10,134 shs
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
$0.32
$0.31
$0.11
$0.46
$2.40M0.371,465 shsN/A
NIMU
Non-Invasive Monitoring Systems
$0.00
$0.01
$0.00
$0.02
$630K0.975,530 shsN/A
XAGE
Longevity Health
$2.44
+0.8%
$0.00
$2.20
$59.40
$2.45M0.4956,876 shs10,621 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%+2.16%+8.88%-53.12%-94.75%
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.00%-7.51%+10.64%+108.52%+127.17%
NIMU
Non-Invasive Monitoring Systems
0.00%-22.64%-31.67%+2.50%-65.25%
XAGE
Longevity Health
0.00%-5.79%+243,999,900.00%+243,999,900.00%+243,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.0975 of 5 stars
0.02.00.00.00.60.00.6
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
N/AN/AN/AN/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/AN/AN/AN/A
XAGE
Longevity Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00
N/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.00
N/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
0.00
N/AN/AN/A
XAGE
Longevity Health
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$250K9.86N/AN/A$10.34 per share0.16
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
$11.98M0.20N/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/AN/A
XAGE
Longevity Health
$50K48.80N/AN/A($6.77) per share-0.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$7.72M-$379.74N/AN/AN/A-322.46%-262.96%8/13/2025 (Estimated)
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
-$130K$0.056.48N/A4.70%45.60%12.66%N/A
NIMU
Non-Invasive Monitoring Systems
-$110KN/A0.00N/AN/AN/A-251.43%N/A
XAGE
Longevity Health
-$10.37MN/A0.00N/A-1,535.11%N/A-280.07%N/A

Latest NIMU, XAGE, BJDX, and ESMC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q3 2025
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
N/A$0.02N/A$0.02N/A$3.47 million
5/13/2025Q1 2025
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A-$3.37N/A-$3.37N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
N/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/A
XAGE
Longevity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
2.71
2.71
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.14
1.92
1.23
NIMU
Non-Invasive Monitoring Systems
N/A
0.03
0.03
XAGE
Longevity Health
N/A
0.42
0.21

Institutional Ownership

CompanyInstitutional Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
N/A
NIMU
Non-Invasive Monitoring Systems
0.12%
XAGE
Longevity Health
24.22%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
91.49 million1.49 millionNot Optionable
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
407.42 million7.27 millionNot Optionable
NIMU
Non-Invasive Monitoring Systems
3154.81 million110.23 millionNot Optionable
XAGE
Longevity Health
141.00 million713,000N/A

Recent News About These Companies

Wall Street Zen Upgrades Longevity Health (NASDAQ:XAGE) to Hold

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$1.66 +0.04 (+2.16%)
Closing price 07/3/2025 03:35 PM Eastern
Extended Trading
$1.64 -0.01 (-0.60%)
As of 07/3/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Escalon Medical stock logo

Escalon Medical OTCMKTS:ESMC

$0.32 0.00 (0.00%)
As of 07/3/2025

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

Non-Invasive Monitoring Systems OTCMKTS:NIMU

$0.0041 0.00 (0.00%)
As of 07/3/2025

Non-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.

Longevity Health NASDAQ:XAGE

$2.44 +0.02 (+0.83%)
As of 07/3/2025 01:00 PM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.